RYAN MCCULLOCH: Open Payments
NPI 1720195530 · CHUBBUCK, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$961 in 67 payments from 14 companies in 2025. Trend: 2023 $830 · 2024 $931 · 2025 $961
Food & beverage: $690Education: $271
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $300 |
| ABBVIE INC. | 9 | $177 |
| Novartis Pharmaceuticals Corporation | 30 | $169 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $81 |
| LEO Pharma Inc. | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| Arcutis Biotherapeutics, Inc. | 2 | $28 |
| UCB, Inc. | 1 | $28 |
| Biofrontera Inc. | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $19 |
Products named: TREMFYA, COSENTYX, SKYRIZI, DUPIXENT, RINVOQ, Zoryve, Bimzelx, ADBRY.
Industry payments across ID — which companies pay providers there.
